NERVGEN PHARMA CORP. Operating Cash Flow

by

Quick Answer

NERVGEN PHARMA CORP. reported operating cash flow of -C$19.50 million for fiscal year 2025 (IFRS, Form 20-F).

Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.

NERVGEN PHARMA CORP. Operating Cash Flow — Annual History

Fiscal Year Operating Cash Flow YoY Change
2025 -C$19.50M -15.8%
2024 -C$16.84M —
  • NERVGEN PHARMA CORP.’s operating cash flow fell 15.8% year over year.
  • The most recent figure is from NERVGEN PHARMA CORP.’s fiscal year 2025 annual report (Form 20-F), filed March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.

Last verified:

Leave a Comment